Orphazyme

Orphazyme is a biopharmaceutical company focused on bringing treatments to patients living with life-threatening or debilitating rare diseases. Its research focuses on developing therapies for diseases caused by misfolding of proteins, including lysosomal storage diseases. Orphazyme is headquartered in Copenhagen, Denmark, and is listed on Nasdaq Copenhagen (ORPHA.CO).